803 related articles for article (PubMed ID: 20889584)
1. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
2. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.
Angulo E; Noé V; Casadó V; Mallol J; Gomez-Isla T; Lluis C; Ferrer I; Ciudad CJ; Franco R
J Neurochem; 2004 Nov; 91(3):547-57. PubMed ID: 15485486
[TBL] [Abstract][Full Text] [Related]
4. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.
Carter TL; Rissman RA; Mishizen-Eberz AJ; Wolfe BB; Hamilton RL; Gandy S; Armstrong DM
Exp Neurol; 2004 Jun; 187(2):299-309. PubMed ID: 15144856
[TBL] [Abstract][Full Text] [Related]
5. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
Zipser BD; Johanson CE; Gonzalez L; Berzin TM; Tavares R; Hulette CM; Vitek MP; Hovanesian V; Stopa EG
Neurobiol Aging; 2007 Jul; 28(7):977-86. PubMed ID: 16782234
[TBL] [Abstract][Full Text] [Related]
6. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
[TBL] [Abstract][Full Text] [Related]
7. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
10. Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease.
Cupidi C; Capobianco R; Goffredo D; Marcon G; Ghetti B; Bugiani O; Tagliavini F; Giaccone G
J Alzheimers Dis; 2010; 19(1):57-68. PubMed ID: 20061626
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
12. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
Thal DR; Härtig W; Schober R
J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
[TBL] [Abstract][Full Text] [Related]
13. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
14. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
15. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
16. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
17. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease.
Iwai A; Masliah E; Sundsmo MP; DeTeresa R; Mallory M; Salmon DP; Saitoh T
Brain Res; 1996 May; 720(1-2):230-4. PubMed ID: 8782917
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
19. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.
López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I
J Neuropathol Exp Neurol; 2015 Apr; 74(4):319-44. PubMed ID: 25756590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]